帕金森病眼球扫视运动异常的多维剖析及干预应用的研究进展

doi:10.3969/j.issn.1004-583X.2025.11.015

摘要/Abstract

摘要：

在近期的临床研究和实践中,帕金森病(Parkinson’s disease, PD)的眼球运动变化日益受到关注。对眼球运动的研究为认识人脑功能和功能障碍提供了重要的窗口。扫视是最常见的眼球运动之一,相关研究也最充分。本文就PD患者眼球扫视运动的研究结果进行综述,包括眼球运动的分类、眼球扫视运动的神经通路、各项检测范式,并重点总结了PD患者扫视运动异常的特点及其与临床症状的相关性,最后介绍了药物及丘脑底核脑深部电刺激对PD患者扫视运动的影响。

关键词: 帕金森病, 眼球运动异常, 扫视, 干预

中图分类号:

R742.5

刘述廷, 曲艳, 崔雅婷, 温瑶, 李晓红. 帕金森病眼球扫视运动异常的多维剖析及干预应用的研究进展[J]. 临床荟萃, 2025, 40(11): 1052-1056.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.lchc.cn/CN/10.3969/j.issn.1004-583X.2025.11.015

https://www.lchc.cn/CN/Y2025/V40/I11/1052

参考文献 43

[1]	Fukushima K, Fukushima J, Barnes GR. Clinical application of eye movement tasks as an aid to understanding Parkinson's disease pathophysiology[J]. Exp Brain Res, 2017, 235(5):1309-1321.doi:10.1007/s00221-017-4916-5. pmid: 28258438
[2]	Li H, Zhang X, Yang Y, et al. Abnormal eye movements in Parkinson's disease: From experimental study to clinical application[J]. Parkinsonism Relat Disord, 2023, 115:105791.doi:10.1016/j.parkreldis.2023.105791.
[3]	Middleton FA, Strick PL. Basal-ganglia ‘projections’ to the prefrontal cortex of the primate[J]. Cereb Cortex, 2002, 12(9):926-935.doi:10.1093/cercor/12.9.926.
[4]	Antoniades CA, Spering M. Eye movements in Parkinson's disease: From neurophysiological mechanisms to diagnostic tools[J]. Trends Neurosci, 2024, 47(1):71-83.doi:10.1016/j.tins.2023.11.001. pmid: 38042680
[5]	Chambers JM, Prescott TJ. Response times for visually guided saccades in persons with Parkinson's disease: A meta-analytic review[J]. Neuropsychologia, 2010, 48(4):887-899.doi:10.1016/j.neuropsychologia.2009.11.006. pmid: 19913042
[6]	Terao Y. Making saccades, fast and slow: The voluntary versus reflexive saccade systems in Parkinson's disease[J]. Clin Neurophysiol, 2022, 143:143-144.doi:10.1016/j.clinph.2022.08.012. pmid: 36089449
[7]	Calabresi P, Picconi B, Tozzi A, et al. Direct and indirect pathways of basal ganglia: A critical reappraisal[J]. Nat Neurosci, 2014, 17(8):1022-1030.doi:10.1038/nn.3743. pmid: 25065439
[8]	Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease[J]. Nat Rev Neurosci, 2017, 18(7):435-450.doi:10.1038/nrn.2017.62. pmid: 28592904
[9]	Gaymard B. Cortical and sub-cortical control of saccades and clinical application[J]. Rev Neurol (Paris), 2012, 168(10):734-740.doi:10.1016/j.neurol.2012.07.016.
[10]	Macaskill MR, Graham CF, Pitcher TL, et al. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease[J]. Neuropsychologia, 2012, 50(14):3338-3347.doi:10.1016/j.neuropsychologia.2012.09.025. pmid: 23000134
[11]	Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients[J]. Trends Neurosci, 1990, 13(7):296-302.doi:10.1016/0166-2236(90)90113-o. pmid: 1695407
[12]	Sereno AB, Holzman PS. Spatial selective attention in schizophrenic, affective disorder, and normal subjects[J]. Schizophr Res, 1996, 20(1-2): 33-50.doi:10.1016/0920-9964(95)00077-1. pmid: 8794492
[13]	林茵, 周梦溪, 姜春燕, 等. 新诊断未用药帕金森病患者的眼球运动特点分析[J]. 中华神经科杂志, 2023, 56(9):976-985.
[14]	Braak H, Rub U, Del Tredici K. Cognitive decline correlates with neuropathological stage in Parkinson's disease[J]. J Neurol Sci, 2006, 248(1-2):255-258.doi:10.1016/j.jns.2006.05.011. pmid: 16814807
[15]	Terao Y, Fukuda H, Yugeta A, et al. Initiation and inhibitory control of saccades with the progression of Parkinson's disease-changes in three major drives converging on the superior colliculus[J]. Neuropsychologia, 2011, 49(7):1794-1806.doi:10.1016/j.neuropsychologia.2011.03.002.
[16]	Armstrong RA. Oculo-visual dysfunction in Parkinson's disease[J]. J Parkinsons Dis, 2015, 5(4):715-726.doi:10.3233/JPD-150686.
[17]	Degos B, Pouget P, Missal M. From anticipation to impulsivity in Parkinson's disease[J]. NPJ Parkinsons Dis, 2022, 8(1):125.doi:10.1038/s41531-022-00393-w. pmid: 36184657
[18]	Terao Y, Tokushige S, Inomata-Terada S, et al. Differentiating early Parkinson's disease and multiple system atrophy with parkinsonism by saccade velocity profiles[J]. Clin Neurophysiol, 2019, 130(12):2203-2215.doi:10.1016/j.clinph.2019.09.004. pmid: 31669865
[19]	Lemos J, Pereira D, Almendra L, et al. Distinct functional properties of the vertical and horizontal saccadic network in health and Parkinson's disease: An eye-tracking and fMRI study[J]. Brain Res, 2016, 1648(Pt A):469-484.doi:10.1016/j.brainres.2016.07.037. pmid: 27545665
[20]	Shaikh AG, Ghasia FF. Saccades in Parkinson's disease: Hypometric, slow, and maladaptive[J]. Prog Brain Res, 2019, 249:81-94.doi:10.1016/bs.pbr.2019.05.001. pmid: 31325999
[21]	Linder J, Wenngren B, Stenlund H, et al. Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism[J]. J Neurol, 2012, 259(6):1206-1214.doi:10.1007/s00415-011-6338-9. pmid: 22173951
[22]	Zhang J, Zhang B, Ren Q, et al. Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson's disease[J]. Neurol Sci, 2021, 42(6):2337-2345.doi:10.1007/s10072-020-04796-6. pmid: 33043395
[23]	Tada M, Nishizawa M, Onodera O. Redefining cerebellar ataxia in degenerative ataxias: Lessons from recent research on cerebellar systems[J]. J Neurol Neurosurg Psychiatry, 2015, 86(8):922-928.doi:10.1136/jnnp-2013-307225. pmid: 25637456
[24]	Bostan AC, Dum RP, Strick PL. The basal ganglia communicate with the cerebellum[J]. Proc Natl Acad Sci U S A, 2010, 107(18):8452-8456.doi:10.1073/pnas.1000496107.
[25]	Pretegiani E, Optican LM. Eye movements in Parkinson's disease and inherited Parkinsonian syndromes[J]. Front Neurol, 2017, 8:592.doi:10.3389/fneur.2017.00592. pmid: 29170650
[26]	Waldthaler J, Stock L, Student J, et al. Antisaccades in Parkinson's disease: A meta-analysis[J]. Neuropsychol Rev, 2021, 31(4):628-642.doi:10.1007/s11065-021-09489-1. pmid: 33742354
[27]	Antoniades CA, Demeyere N, Kennard C, et al. Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study[J]. Mov Disord, 2015, 30(6):843-847.doi:10.1002/mds.26134.
[28]	Waldthaler J, Tsitsi P, Svenningsson P. Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson's disease[J]. NPJ Parkinsons Dis, 2019, 5:11.doi:10.1038/s41531-019-0083-7. pmid: 31263745
[29]	Munoz DP, Everling S. Look away: The anti-saccade task and the voluntary control of eye movement[J]. Nat Rev Neurosci, 2004, 5(3):218-228.doi:10.1038/nrn1345. pmid: 14976521
[30]	Ma W, Li M, Wu J, et al. Multiple step saccades in simply reactive saccades could serve as a complementary biomarker for the early diagnosis of Parkinson's disease[J]. Front Aging Neurosci, 2022, 14:912967.doi:10.3389/fnagi.2022.912967.
[31]	Pelzer EA, Dillenburger B, Grundmann S, et al. Hypomania and saccadic changes in Parkinson's disease: Influence of D2 and D3 dopaminergic signalling[J]. NPJ Parkinsons Dis, 2020, 6:5.doi:10.1038/s41531-019-0107-3. pmid: 31970287
[32]	Gallea C, Wicki B, Ewenczyk C, et al. Antisaccade, a predictive marker for freezing of gait in Parkinson's disease and gait/gaze network connectivity[J]. Brain, 2021, 144(2):504-514.doi:10.1093/brain/awaa407. pmid: 33279957
[33]	Carpenter MG, Bloem BR. A new twist on turning movements in Parkinson's disease patients[J]. Mov Disord, 2011, 26(12):2151-2153.doi:10.1002/mds.23980.
[34]	Kelly VE, Johnson CO, McGough EL, et al. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease[J]. Parkinsonism Relat Disord, 2015, 21(7):692-697.doi:10.1016/j.parkreldis.2015.04.002.
[35]	Munoz MJ, Reilly JL, Pal GD, et al. Medication adversely impacts visually-guided eye movements in Parkinson's disease[J]. Clin Neurophysiol, 2022, 143:145-153.doi:10.1016/j.clinph.2022.07.505. pmid: 35995722
[36]	Yu Y, Yan W, Xu X, et al. Response times for reflexive saccades correlate with cognition in Parkinson's disease, not disease severity or duration[J]. Front Neurol, 2022, 13:945201.doi:10.3389/fneur.2022.945201.
[37]	Mestre TA, Fereshtehnejad S, Berg D, et al. Parkinson's disease subtypes: Critical appraisal and recommendations[J]. J Parkinsons Dis, 2021, 11(2):395-404.doi:10.3233/JPD-202472.
[38]	Barbosa P, Kaski D, Castro P, et al. Saccadic direction errors are associated with impulsive compulsive behaviours in Parkinson's disease patients[J]. J Parkinsons Dis, 2019, 9(3):625-630.doi:10.3233/JPD-181460.
[39]	Saranza G, Lang AE. Levodopa challenge test: Indications, protocol, and guide[J]. J Neurol, 2021, 268(9):3135-3143.doi:10.1007/s00415-020-09810-7.
[40]	Terao Y, Fukuda H, Ugawa Y, et al. New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: A clinical review[J]. Clin Neurophysiol, 2013, 124(8):1491-1506.doi:10.1016/j.clinph.2013.01.021. pmid: 23499161
[41]	Fawcett AP, Gonzalez EG, Moro E, et al. Subthalamic nucleus deep brain stimulation improves saccades in Parkinson's disease[J]. Neuromodulation, 2010, 13(1):17-25.doi:10.1111/j.1525-1403.2009.00246.x. pmid: 21992760
[42]	Munoz MJ, Goelz LC, Pal GD, et al. Increased subthalamic nucleus deep brain stimulation amplitude impairs inhibitory control of eye movements in Parkinson's disease[J]. Neuromodulation, 2022, 25(6):866-876.doi:10.1111/ner.13476.
[43]	Mitchell T, Lehericy S, Chiu SY, et al. Emerging neuroimaging biomarkers across disease stage in Parkinson disease: A review[J]. JAMA Neurol, 2021, 78(10):1262-1272.doi:10.1001/jamaneurol.2021.1312. pmid: 34459865

帕金森病眼球扫视运动异常的多维剖析及干预应用的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 43

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙楠, 杨凯琦, 唐亚赛, 谢小华, 吕佩源, 董艳红. 帕金森病认知障碍的治疗新进展[J]. 临床荟萃, 2025, 40(8): 748-752.
[2]	胡泽林, 吴美璇, 梅佳, 孟书静, 张强, 秦殿菊. 膝骨关节炎患者运动干预的证据总结[J]. 临床荟萃, 2024, 39(5): 396-400.
[3]	李倩, 钟平. 帕金森病伴脑白质病变患者临床特征及危险因素分析[J]. 临床荟萃, 2024, 39(3): 222-226.
[4]	王九雪, 李娜, 靳玮, 王硕, 常雅君, 王天俊. 帕金森病患者血清尿酸、同型半胱氨酸和胱抑素C水平与运动症状及认知功能的相关性[J]. 临床荟萃, 2024, 39(2): 125-129.
[5]	张娜文, 黄少敏, 田利民. 2型糖尿病与帕金森病相关性研究的进展[J]. 临床荟萃, 2023, 38(9): 845-850.
[6]	周正新, 梁秋雄, 陈江瑛. 胰高血糖素样肽-1在帕金森病“肠-脑轴”中的作用研究进展[J]. 临床荟萃, 2023, 38(9): 855-858.
[7]	杨鑫, 许华娇. 基于Web of Science糖尿病患者心理干预研究的文献计量学分析[J]. 临床荟萃, 2023, 38(8): 731-736.
[8]	王璐璐, 董露露, 江超, 王九雪, 常雅君, 王天俊. 弥散张量成像评估帕金森病合并非运动症状患者脑微结构的研究进展[J]. 临床荟萃, 2023, 38(2): 189-192.
[9]	陈轩轩, 高树贵. 改良无抽搐电休克治疗抑郁症所致记忆损害临床干预策略[J]. 临床荟萃, 2023, 38(1): 75-78.
[10]	孙亚南, 郝一峰, 李晓红. 肛门括约肌肌电图对多系统萎缩与帕金森病鉴别诊断价值的Meta分析[J]. 临床荟萃, 2022, 37(6): 490-496.
[11]	王璐璐, 董露露, 王天俊. 多巴胺转运体^99mTc-TRODAT-1 SPECT显像在帕金森病诊断中的研究进展[J]. 临床荟萃, 2022, 37(5): 463-466.
[12]	郭畅, 沈慧楠, 孙艺萌, 王东玉. 血脂、同型半胱氨酸与帕金森病合并认知障碍相关性[J]. 临床荟萃, 2022, 37(2): 128-132.
[13]	李文君, 张策, 刘俊艳. 改善循环治疗加重帕金森病患者体位性低血压1例[J]. 临床荟萃, 2022, 37(10): 934-937.
[14]	但佳惠, 王相明, 张月辉. 磁共振成像对帕金森病诊断价值的研究进展[J]. 临床荟萃, 2021, 36(5): 476-480.
[15]	孟柳明, 毛璐易, 何慕琰, 张秋燕. PCT、CRP、IL-8联合预测小儿支气管炎的激素干预疗效的价值[J]. 临床荟萃, 2021, 36(10): 942-945.